COVID-19 and cystic fibrosis: Diagnostic difficulties or incorrect methods?

Samuel Pecho-Silva, Ana Claudia Navarro-Solsol, Vicky Panduro-Correa, Kovy Arteaga-Livias, Alfonso J. Rodriguez-Morales, Kuldeep Dhama

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

1 Cita (Scopus)

Resumen

Cystic fibrosis (CF) is a chronic lung disease with wide distribution worldwide. With the appearance of the Coronavirus Disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), difficulties arise when evaluating, diagnosing, and treating patients with other conditions, including CF. We present the case of a patient with CF who had a definite serological diagnosis, a CT scan suggestive of SARS-CoV-2 infection/COVID-19, and a negative molecular test (RT-PCR), with rapid resolution of symptoms and early discharge. CF/SARS-CoV-2 comorbidity needs to be adequately studied and assessed in the context of the COVID-19 pandemic.

Idioma originalInglés
Páginas (desde-hasta)1681-1685
Número de páginas5
PublicaciónJournal of Pure and Applied Microbiology
Volumen14
N.º3
DOI
EstadoPublicada - set. 2020

Huella

Profundice en los temas de investigación de 'COVID-19 and cystic fibrosis: Diagnostic difficulties or incorrect methods?'. En conjunto forman una huella única.

Citar esto